Seraprevir

DRUG2 trials

Sponsors

Ginkgopharma CO., LTD

Conditions

Hepatitis C Virus Infection

Phase 2

Study of Seraprevir in Combination With Sofosbuvir in Chronic Genotype 2,3,6 Hepatitis C Virus Infection Patients

Ginkgopharma CO., LTDHepatitis C Virus Infection

Start: 2019-04-03End: 2020-08-31Target: 36Updated: 2019-10-01

Phase 3

Study of Seraprevir in Combination With Sofosbuvir in Chronic Genotype 1 Hepatitis C Virus Infection Patients

Ginkgopharma CO., LTDHepatitis C Virus Infection

Start: 2018-10-17End: 2019-11-30Updated: 2019-06-28